Gottlieb: FDA to Expand Non-Prescription Access to Drugs in 2018

Drug Industry Daily
A A
In the coming year, the FDA’s top priorities will include broadening non-prescription access to drugs and updating compounder regulations, according to Commissioner Scott Gottlieb.

To View This Article:

Login

Subscribe To Drug Industry Daily